Paxil CR is a controlled-release version of paroxetine, an antidepressant in the SSRI (selective serotonin reuptake inhibitor) class. The “CR” stands for controlled release, meaning the tablet is engineered to dissolve slowly and deliver the medication gradually over several hours rather than all at once. It comes in 12.5 mg, 25 mg, and 37.5 mg tablets and is FDA-approved to treat major depressive disorder, panic disorder, and premenstrual dysphoric disorder (PMDD).
How the Controlled-Release Tablet Works
Inside each Paxil CR tablet is a layered polymer matrix that controls how fast the drug dissolves. Once you swallow it, nothing happens right away. An enteric coating on the outside prevents the tablet from breaking down in your stomach. Only after it passes into the small intestine does the medication begin to release, and then it does so gradually over about four to five hours.
This design exists largely to reduce nausea, one of the most common complaints with standard paroxetine. In a clinical study comparing the two formulations at the same dose, 59% of people taking immediate-release paroxetine experienced nausea or vomiting, compared to 40% of those taking the enteric-coated controlled-release version. That’s a meaningful difference for a side effect that often causes people to stop taking the medication early. Because the controlled-release mechanism depends on the tablet’s structure, you should swallow Paxil CR whole. Crushing or chewing it would defeat the slow-release design and dump the full dose at once.
Conditions It Treats
For major depressive disorder, the typical starting dose is 25 mg once daily. For panic disorder, treatment starts lower at 12.5 mg per day, since people with panic disorder can be more sensitive to initial side effects from SSRIs.
Paxil CR also has an unusual approval for PMDD, which causes severe mood symptoms tied to the menstrual cycle. The starting dose for PMDD is 12.5 mg per day, with a maximum of 25 mg. What makes this approval distinctive is that it offers two dosing schedules: you can take it every day throughout your cycle (continuous dosing) or only during the roughly two weeks before your period begins (intermittent dosing). The intermittent option, which starts 14 days before the expected onset of menstruation and stops when bleeding begins, appeals to people who prefer not to take a daily antidepressant year-round.
Common Side Effects
Paxil CR shares the side effect profile typical of SSRIs. Nausea is common, though less so than with the immediate-release version. Other frequently reported effects include headache, drowsiness, insomnia, dry mouth, constipation, dizziness, and sweating. Sexual side effects, including decreased libido and difficulty reaching orgasm, are well-documented with paroxetine and often the reason people switch to a different antidepressant.
Weight gain is another concern that tends to emerge over months rather than weeks. Among SSRIs, paroxetine has a reputation for being more likely to cause weight changes than some alternatives.
The Boxed Warning on Suicidality
Like all antidepressants, Paxil CR carries an FDA boxed warning about an increased risk of suicidal thinking and behavior in children and adolescents. In pooled clinical trial data, 4% of young people taking antidepressants experienced suicidal thoughts or behavior, compared to 2% on placebo. This risk is highest in the first few months of treatment. The warning emphasizes close monitoring during early treatment, especially for anyone under 25. No completed suicides occurred in the pediatric trials that led to this warning, but the signal was strong enough to warrant the highest level of FDA caution.
Drug Interactions Worth Knowing
Paroxetine is a potent inhibitor of a liver enzyme called CYP2D6, which the body uses to break down a long list of other medications. When Paxil CR blocks that enzyme, those other drugs can build up to higher-than-expected levels in the bloodstream.
One interaction with real clinical stakes involves tamoxifen, a drug used to treat and prevent breast cancer. Tamoxifen actually needs CYP2D6 to convert it into its active form, so paroxetine can reduce its effectiveness. Studies have linked this combination to a higher risk of breast cancer relapse. People taking tamoxifen are generally advised to use a different antidepressant entirely.
Paroxetine can also raise blood levels of certain heart rhythm medications, beta-blockers like metoprolol, and some antipsychotics. Your prescriber should review your full medication list before starting Paxil CR, because dosage adjustments for other drugs may be necessary.
Stopping Paxil CR Safely
Paroxetine leaves the body faster than most other SSRIs, which makes it one of the antidepressants most likely to cause withdrawal symptoms if stopped abruptly. Discontinuation syndrome can include dizziness, flu-like symptoms, irritability, anxiety, and a distinctive sensation people describe as “brain zaps,” brief electric-shock-like feelings in the head.
These symptoms are not dangerous, but they can be intensely uncomfortable and are sometimes mistaken for a relapse of the underlying condition. The key difference: discontinuation symptoms often include physical complaints like dizziness, nausea, and sensory disturbances that aren’t typical of depression itself.
Tapering gradually over weeks to months significantly reduces the likelihood and severity of these symptoms. People who stop quickly, over one to seven days, are more likely to relapse within months compared to those who reduce the dose over two or more weeks. Some clinicians will switch a patient to a longer-acting antidepressant first, then taper that drug instead, because it clears the body more slowly and produces a gentler transition. The bottom line: never stop Paxil CR cold turkey. A slow, planned taper makes the process far more manageable.
How It Compares to Regular Paxil
Paxil CR and standard Paxil contain the same active ingredient, paroxetine. The difference is entirely in how the tablet delivers it. The controlled-release version produces a more gradual rise in blood levels, which is why nausea rates drop significantly. Both formulations are taken once daily, so convenience is the same.
One practical distinction: Paxil CR’s available strengths (12.5, 25, and 37.5 mg) don’t line up exactly with the immediate-release version’s strengths (10, 20, 30, and 40 mg), so switching between formulations isn’t a simple one-to-one swap. If you’re considering switching from one to the other, your prescriber will need to select the closest equivalent dose.